FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2945268093> ?p ?o ?g. }

• W2945268093 endingPage "2072" @default.
• W2945268093 startingPage "2072" @default.
• W2945268093 abstract "Excessive accumulation of extracellular matrix (ECM) in the trabecular meshwork (TM) reduces aqueous humor outflow, which likely contributes to elevation of IOP in primary open-angle glaucoma (POAG). Salidroside, a phenolic glycoside isolated from Rhodiola rosea is reported to prevent profibrotic responses by inhibiting Smad signaling pathway activated by TGF-β in liver, lung, and kidney tissues. We tested if salidroside can (1) inhibit TGF-β2-induced ECM expression in cultured human TM cells, and (2) lower TGF-β2-induced ocular hypertension in the mouse.Cultured human TM cells stimulated with 5 ng/mL TGF-β2 for 48 hours were treated with salidroside for 24 hours. The expressions of fibronectin (FN), collagen type IV (COL-IV), and laminin (LN) were evaluated by quantitative PCR, Western blot, and immunocytochemistry. BALB/cJ mice were injected intravitreally with an adenoviral vector encoding a bioactive mutant of TGF-β2 (Ad.hTGF-β2226/228) in one eye to induce ocular hypertension, with the uninjected contralateral or Ad.Empty-injected eyes serving as controls. Mice were treated with a daily intraperitoneal injection of 40 mg/kg salidroside. Conscious mouse IOP values were measured using a TonoLab rebound tonometer.In cultured human TM cells, treatment with TGF-β2 increased expressions of FN, COL-IV, and LN, as assessed by quantitative PCR, Western blotting, and immunocytochemistry, all of which were significantly and completely ameliorated by 30 μM salidroside. Daily intraperitoneal injections of salidroside (40 mg/kg), starting either at day 0 (same day as Ad.hTGF-β2226/228 injection) or at day 14, significantly lowered TGF-β2-induced ocular hypertension in the mouse. In contrast, salidroside did not affect IOP of control eyes.These results demonstrated that salidroside is capable of minimizing TGF-β2-induced ECM expression in cultured human TM cells. It also reduced TGF-β2-induced ocular hypertension in the mouse. These findings indicate that this phenolic glycoside may be useful as a novel treatment for POAG." @default.
• W2945268093 created "2019-05-29" @default.
• W2945268093 creator A5001836351 @default.
• W2945268093 creator A5004077485 @default.
• W2945268093 creator A5004669303 @default.
• W2945268093 creator A5030736220 @default.
• W2945268093 creator A5073994421 @default.
• W2945268093 creator A5086502210 @default.
• W2945268093 date "2019-05-15" @default.
• W2945268093 modified "2023-10-17" @default.
• W2945268093 title "Effects of Salidroside on Trabecular Meshwork Cell Extracellular Matrix Expression and Mouse Intraocular Pressure" @default.
• W2945268093 cites W1971967234 @default.
• W2945268093 cites W1996554557 @default.
• W2945268093 cites W1997510713 @default.
• W2945268093 cites W2010538186 @default.
• W2945268093 cites W2021769659 @default.
• W2945268093 cites W2024048826 @default.
• W2945268093 cites W2024877051 @default.
• W2945268093 cites W2026568179 @default.
• W2945268093 cites W2028243025 @default.
• W2945268093 cites W2030353509 @default.
• W2945268093 cites W2032731418 @default.
• W2945268093 cites W2037813512 @default.
• W2945268093 cites W2040024127 @default.
• W2945268093 cites W2041208206 @default.
• W2945268093 cites W2043243292 @default.
• W2945268093 cites W2047510146 @default.
• W2945268093 cites W2073537216 @default.
• W2945268093 cites W2078077142 @default.
• W2945268093 cites W2080848479 @default.
• W2945268093 cites W2091028498 @default.
• W2945268093 cites W2099842384 @default.
• W2945268093 cites W2110897487 @default.
• W2945268093 cites W2114333156 @default.
• W2945268093 cites W2141479713 @default.
• W2945268093 cites W2180177645 @default.
• W2945268093 cites W2221753211 @default.
• W2945268093 cites W2412930035 @default.
• W2945268093 cites W2793740592 @default.
• W2945268093 cites W2809139588 @default.
• W2945268093 cites W4240661191 @default.
• W2945268093 doi "https://doi.org/10.1167/iovs.19-26585" @default.
• W2945268093 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31091314" @default.
• W2945268093 hasPublicationYear "2019" @default.
• W2945268093 type Work @default.
• W2945268093 sameAs 2945268093 @default.
• W2945268093 citedByCount "10" @default.
• W2945268093 countsByYear W29452680932020 @default.
• W2945268093 countsByYear W29452680932021 @default.
• W2945268093 countsByYear W29452680932022 @default.
• W2945268093 countsByYear W29452680932023 @default.
• W2945268093 crossrefType "journal-article" @default.
• W2945268093 hasAuthorship W2945268093A5001836351 @default.
• W2945268093 hasAuthorship W2945268093A5004077485 @default.
• W2945268093 hasAuthorship W2945268093A5004669303 @default.
• W2945268093 hasAuthorship W2945268093A5030736220 @default.
• W2945268093 hasAuthorship W2945268093A5073994421 @default.
• W2945268093 hasAuthorship W2945268093A5086502210 @default.
• W2945268093 hasBestOaLocation W29452680931 @default.
• W2945268093 hasConcept C104317684 @default.
• W2945268093 hasConcept C118487528 @default.
• W2945268093 hasConcept C126322002 @default.
• W2945268093 hasConcept C134018914 @default.
• W2945268093 hasConcept C153911025 @default.
• W2945268093 hasConcept C185592680 @default.
• W2945268093 hasConcept C189165786 @default.
• W2945268093 hasConcept C2776415932 @default.
• W2945268093 hasConcept C2777439193 @default.
• W2945268093 hasConcept C2779526882 @default.
• W2945268093 hasConcept C2780159080 @default.
• W2945268093 hasConcept C2781092963 @default.
• W2945268093 hasConcept C2781121420 @default.
• W2945268093 hasConcept C28406088 @default.
• W2945268093 hasConcept C35866371 @default.
• W2945268093 hasConcept C55493867 @default.
• W2945268093 hasConcept C71924100 @default.
• W2945268093 hasConcept C85265743 @default.
• W2945268093 hasConcept C86492073 @default.
• W2945268093 hasConcept C86803240 @default.
• W2945268093 hasConcept C98274493 @default.
• W2945268093 hasConceptScore W2945268093C104317684 @default.
• W2945268093 hasConceptScore W2945268093C118487528 @default.
• W2945268093 hasConceptScore W2945268093C126322002 @default.
• W2945268093 hasConceptScore W2945268093C134018914 @default.
• W2945268093 hasConceptScore W2945268093C153911025 @default.
• W2945268093 hasConceptScore W2945268093C185592680 @default.
• W2945268093 hasConceptScore W2945268093C189165786 @default.
• W2945268093 hasConceptScore W2945268093C2776415932 @default.
• W2945268093 hasConceptScore W2945268093C2777439193 @default.
• W2945268093 hasConceptScore W2945268093C2779526882 @default.
• W2945268093 hasConceptScore W2945268093C2780159080 @default.
• W2945268093 hasConceptScore W2945268093C2781092963 @default.
• W2945268093 hasConceptScore W2945268093C2781121420 @default.
• W2945268093 hasConceptScore W2945268093C28406088 @default.
• W2945268093 hasConceptScore W2945268093C35866371 @default.
• W2945268093 hasConceptScore W2945268093C55493867 @default.
• W2945268093 hasConceptScore W2945268093C71924100 @default.
• W2945268093 hasConceptScore W2945268093C85265743 @default.

• next